Novartis Ag (NVS) DMA 100 (1992 - 2026)
Novartis Ag (NVS) DMA 100 (1992 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
DMA 100 |
| 1 |
Gsk |
92,134,969.93 Bn |
92,134,964.97 Bn |
7.76 Bn |
54.05 |
| 2 |
Eli Lilly |
1,027.45 Bn |
1,022.17 Bn |
16.22 Bn |
994.66 |
| 3 |
Johnson & Johnson |
559.08 Bn |
537.03 Bn |
15.96 Bn |
233.90 |
| 4 |
AbbVie |
394.75 Bn |
385.40 Bn |
10.78 Bn |
215.94 |
| 5 |
Merck |
295.12 Bn |
289.47 Bn |
12.09 Bn |
116.25 |
| 6 |
Amgen |
186.65 Bn |
174.61 Bn |
5.87 Bn |
350.97 |
| 7 |
Gilead Sciences |
159.22 Bn |
151.50 Bn |
5.52 Bn |
138.62 |
| 8 |
Pfizer |
146.00 Bn |
133.23 Bn |
-1.21 Bn |
26.66 |
| 9 |
Bristol Myers Squibb |
113.22 Bn |
102.77 Bn |
8.07 Bn |
58.33 |
| 10 |
Novartis Ag |
108.02 Bn |
107.33 Bn |
- |
152.33 |
| Date | Value |
|---|
| Jun 8, 2026 |
152.33 |
| Jun 5, 2026 |
152.28 |
| Jun 4, 2026 |
152.20 |
| Jun 3, 2026 |
152.13 |
| Jun 2, 2026 |
152.11 |
| Jun 1, 2026 |
152.10 |
| May 29, 2026 |
152.07 |
| May 28, 2026 |
151.94 |
| May 27, 2026 |
151.82 |
| May 26, 2026 |
151.68 |
| May 22, 2026 |
151.56 |
| May 21, 2026 |
151.44 |
| May 20, 2026 |
151.31 |
| May 19, 2026 |
151.19 |
| May 18, 2026 |
151.08 |
| May 15, 2026 |
150.96 |
| May 14, 2026 |
150.84 |
| May 13, 2026 |
150.69 |
| May 12, 2026 |
150.55 |
| May 11, 2026 |
150.41 |
